Medicine related problems in adult patients with af on doacs

• At: Glasgow (Scotland) (2018)
• Type: Poster
• Poster code: POS-HPS-008
• By: ALEWAIRDHI, Huda (University of Hertfordshire, Department of Pharmacy, Pharmacology and Postgraduate Medicine)
• Co-author(s): Huda Alewairdhi
  Nkiruka Umaru: Department of Pharmacy, Pharmacology and Postgraduate Medicine, University of Hertfordshire, Hatfield, United Kingdom
  Zoe Aslanpour: Department of Pharmacy, Pharmacology and Postgraduate Medicine, University of Hertfordshire, Hatfield, United Kingdom
  
• Abstract:

  Background

  Anticoagulants are recommended to prevent stroke and systemic embolism in Atrial Fibrillation (AF) and are a significant cause of patient safety incidents. Recently, direct oral anticoagulants (DOACs) have been developed as alternatives to traditional anticoagulant such warfarin. Although clinical trials data shows a similar adverse drug ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login